Cynapsus Therapeutics IPO Research Information

Cynapsus Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Cynapsus Therapeutics, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Cynapsus Therapeutics	CYNA - NASDAQ	Last trade $14.18	$0.00	$0.00	4.5 million	6/18/2015
Underwriter(s): BofA Merrill Lynch, Nomura
Co-Manager(s): Noble Life Science Partners
Industry:
Filing(s): Filed 2015-06-09

About Cynapsus Therapeutics (adapted from Cynapsus Therapeutics prospectus):
Currently, the outstanding common shares are listed and posted for trading on the Toronto Stock Exchange, or TSX, under the symbol 'CTH'. We have applied to list our common shares (including the common shares being distributed hereunder) on the NASDAQ Capital Market, or NASDAQ, under the symbol 'CYNA'.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "CYNA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.